BioNJ’s C-Suite Summit
Event is closed to the media.
With Insights from McKinsey & Company
SAVE THE DATE!
Thursday, October 25, 2018, Bridgewater Marriott
Healthcare in Transformation:
Digitization, Innovation and Consumerization
7:00 a.m. – 8:15 a.m. Registration & Networking Breakfast Buffet
8:15 a.m. – 8:30 a.m. Welcome & Opening Remarks by Debbie Hart, President & CEO, BioNJ
8:30 a.m. – 9:15 a.m. Keynote: The Next S-Curve of Opportunity
9:15 a.m. – 10:00 a.m. Perspectives: Implications of the Transforming Ecosystem for Innovation
Industry leaders will share learnings, short- and long-term implications for innovation, marketplace dynamics and the leadership role life sciences companies will play.
10:00 a.m. – 10:30 a.m. Keynote: Addressing Affordability and Access
10:30 a.m.– 11:00 a.m. Networking Break
11:00 a.m. – 11:45 p.m. Panel: The Empowered Patient
A panel discussion on ways that patients are becoming increasingly informed and empowered, particularly through digital channels. The panel will touch on implications for policy, data privacy, patient-centric drug development.
11:45 p.m. – 12:45 p.m. Lunch
Interviewer: Francois Nader, Ph.D., Chair, Acceleron Pharma
A panel discussion on new business models that are emerging and the role that “non-traditional” players are now playing in healthcare. The panel will explore how these shifts are altering the landscape of R&D, funding and sustainability, life cycle management and overall healthcare delivery, as well as presenting new opportunities for life sciences companies to forge collaborations.
2:00 p.m. – 2:15 p.m. Networking Break
2:15 p.m. – 2:45 p.m. Fireside Chat: The Talent Gap
This session will explore an increasingly evident shortage of talent in this integrated digital age, and the implications for life sciences companies. What do industry leaders need to be doing to build the capabilities necessary to succeed in today’s dynamic environment? What strategies should be in place to cultivate, develop and retain the next generation of leaders?
2:45 p.m. – 3:15 p.m. Keynote: Industry Implications on the Regulatory Horizon
3:15 p.m. – 3:30 p.m. Closing Remarks by James Sapirstein, R.Ph., M.B.A., CEO, ContraVir Pharmaceuticals and Debbie Hart, President & CEO, BioNJ
3:30 p.m. – 4:00 p.m. Dessert Networking Reception